Kalbe Farma

PT Kalbe Farma Tbk (pronounced in American English as K-ahl-bee, Japanese: か儿べ製薬株式会社) is a pharmaceutical, healthcare and nutrition company with offices in Tokyo and North Jakarta, established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).[1]

PT Kalbe Farma Tbk
Kalbe Farmaceuticals (Japan) Inc.
Native name
か儿べ製薬株式会社
Kalbe Seiyaku Kabushiki gaisha
TypePublic, Kabushiki gaisha
IDX: KLBF
Industry
FoundedSeptember 10, 1966
HeadquartersJakarta, Indonesia
Area served
Cambodia, Malaysia, Japan, United States, Canada, Myanmar, Philippines, Thailand, Vietnam, Sri Lanka, South Africa and Nigeria
Key people
Vidjongtius
Revenue Rp 15.678 trillion (YTD Q3 2018)
Rp 1.834 trillion (YTD Q3 2018)
Total assets Rp 17.531 trillion (YTD Q3 2018)
Number of employees
17,000 (YTD Q3 2018)
Subsidiaries
  • Bintang Toedjoe
  • KALBE Nutritionals
  • Kalbe Genexine Biologics
  • Innogene Kalbiotech Pte Ltd.
  • Bifarma Adiluhung
  • Kalbe International Pte. Ltd.
  • Innolab Sains Internasional
  • Pharma Metric Labs
  • Saka Farma Laboratories
  • Dankos Farma
  • Hexpharm Jaya Laboratories
  • Hale International
  • Finusolprima Farma Internasional
  • Kalbe Milko Indonesia
  • Enseval Putera
  • Indogravure
  • Kalbe Morinaga
  • Kalbe Vision Pte. Ltd
Websitewww.kalbe.co.id

Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen and Extra Joss.

Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion.

History

Kalbe Farma was founded on September 10, 1966, by 6 siblings, K.L. Tjoen, Theresia H. Setiady, Khouw Lip Swan, Khouw Lip Boen (Also Known As: Dr. Boenyamin Setiawan), Maria Karmila, and F. Bing Aryanto. Kalbe Farma first began operations in a house garage that was owned by the founders.

In May 2020, Kalbe Farma signed a Memorandum of Understanding with South Korean pharmaceuticals company Genexine Inc. to develop a vaccine for the new corona virus or COVID-19.[2]

References
  1. Grafton-Green, Patrick (1 October 2017). "Anti-abortion MP Jacob Rees-Mogg admits profits from abortion pills". Evening Standard. Retrieved 25 March 2020.
  2. "Kalbe Farma and South Korea's Genexine to Start Human Trial for Covid-19 Vaccine". Jakarta Globe. Retrieved 2020-09-06.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.